Revvity, Inc.

NYSE:RVTY 株式レポート

時価総額：US$15.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Revvity 過去の業績

過去 基準チェック /06

Revvityの収益は年間平均-5.6%の割合で減少していますが、 Life Sciences業界の収益は年間 増加しています。収益は年間14.2% 1.1%割合で 減少しています。 Revvityの自己資本利益率は2.5%であり、純利益率は7.3%です。

主要情報

-5.6%

収益成長率

-7.7%

EPS成長率

Life Sciences 業界の成長21.5%
収益成長率-1.1%
株主資本利益率2.5%
ネット・マージン7.3%
前回の決算情報30 Jun 2024

最近の業績更新

Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality

Feb 13
Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality

Recent updates

Getting In Cheap On Revvity, Inc. (NYSE:RVTY) Might Be Difficult

Aug 21
Getting In Cheap On Revvity, Inc. (NYSE:RVTY) Might Be Difficult

When Should You Buy Revvity, Inc. (NYSE:RVTY)?

Jul 16
When Should You Buy Revvity, Inc. (NYSE:RVTY)?

Revvity: Continued Struggles, 2024 Becoming A Lost Year

Jul 03

Is Revvity (NYSE:RVTY) Using Too Much Debt?

Jun 10
Is Revvity (NYSE:RVTY) Using Too Much Debt?

Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Apr 03
Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Revvity: Enter Now As Reorganization Takes Shape

Mar 21

We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt

Feb 28
We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt

Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality

Feb 13
Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality

Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now?

Jan 19
Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now?

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 49% Undervalued

Jan 04
An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 49% Undervalued

Revvity: More Than A Name Change Is Needed For PerkinElmer

Dec 29

Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Dec 20
Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Is Revvity (NYSE:RVTY) Using Too Much Debt?

Oct 07
Is Revvity (NYSE:RVTY) Using Too Much Debt?

Revvity: Recent Investments, Acquisitions, Not Pulling Economic Weight (Rating Downgrade)

Oct 04

At US$108, Is Revvity, Inc. (NYSE:RVTY) Worth Looking At Closely?

Sep 22
At US$108, Is Revvity, Inc. (NYSE:RVTY) Worth Looking At Closely?

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 40% Undervalued

Aug 17
An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 40% Undervalued

Revvity: New Name - But New Investment Outlook? Reiterate Buy

Jul 18

Revvity (NYSE:RVTY) Seems To Use Debt Quite Sensibly

Jul 03
Revvity (NYSE:RVTY) Seems To Use Debt Quite Sensibly

What Does Revvity, Inc.'s (NYSE:RVTY) Share Price Indicate?

Jun 17
What Does Revvity, Inc.'s (NYSE:RVTY) Share Price Indicate?

Calculating The Fair Value Of Revvity, Inc. (NYSE:PKI)

May 16
Calculating The Fair Value Of Revvity, Inc. (NYSE:PKI)

We Think PerkinElmer (NYSE:PKI) Can Stay On Top Of Its Debt

Mar 28
We Think PerkinElmer (NYSE:PKI) Can Stay On Top Of Its Debt

When Should You Buy PerkinElmer, Inc. (NYSE:PKI)?

Mar 13
When Should You Buy PerkinElmer, Inc. (NYSE:PKI)?

PerkinElmer Q4 2022 Earnings Preview

Feb 13

A Look At The Intrinsic Value Of PerkinElmer, Inc. (NYSE:PKI)

Feb 10
A Look At The Intrinsic Value Of PerkinElmer, Inc. (NYSE:PKI)

PerkinElmer: Capital Budgeting A Key Factor To The Investment Debate

Jan 31

Danaher earnings weigh on other life sciences tools, services companies

Jan 24

PerkinElmer says Q4 results will meet or exceed prior guidance

Jan 09

PerkinElmer (NYSE:PKI) Has A Pretty Healthy Balance Sheet

Dec 27
PerkinElmer (NYSE:PKI) Has A Pretty Healthy Balance Sheet

収支内訳

Revvity の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

NYSE:RVTY 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Jun 242,708197942202
31 Mar 242,726183943211
31 Dec 232,751180942217
01 Oct 232,796213898222
02 Jul 232,837250903222
02 Apr 233,024353918221
01 Jan 233,312513940222
02 Oct 223,5995991,001222
03 Jul 223,748637989219
03 Apr 223,483694885195
02 Jan 223,828889854200
03 Oct 214,1551,086893197
04 Jul 214,2571,155893197
04 Apr 214,4381,074961217
03 Jan 212,663631729146
04 Oct 203,234412887196
05 Jul 202,977294866191
05 Apr 202,887226845190
29 Dec 192,884228833189
29 Sep 192,835235806194
30 Jun 192,802251794197
31 Mar 192,783247790196
30 Dec 182,778237809194
30 Sep 182,663128761180
01 Jul 182,543149719166
01 Apr 182,387147667152
31 Dec 172,257157615139
01 Oct 172,182258587135
02 Jul 172,142215580129
02 Apr 172,132210584128
01 Jan 172,116216585124
02 Oct 161,999198574108
03 Jul 162,048199583110
03 Apr 162,076190583110
03 Jan 162,105189586113
04 Oct 152,263176661127
28 Jun 152,241164657126
29 Mar 152,234167656124
28 Dec 142,070130648108
28 Sep 142,221203576123
29 Jun 142,201201577124
30 Mar 142,185176579128
29 Dec 132,158174581132

質の高い収益: RVTYには$145.5M } という大きな 一回限りの 損失があり、過去 12 か月の財務実績が30th June, 2024に影響を及ぼしています。

利益率の向上: RVTYの現在の純利益率 (6.7%)は、昨年(11.8%)よりも低くなっています。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: RVTYの収益は過去 5 年間で年間5.6%減少しました。

成長の加速: RVTYは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。

収益対業界: RVTYは過去 1 年間で収益成長率がマイナス ( -21.9% ) となったため、 Life Sciences業界平均 ( -10.8% ) と比較することが困難です。

株主資本利益率

高いROE: RVTYの 自己資本利益率 ( 2.5% ) は 低い とみなされます。

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

7D

1Y

7D

1Y

7D

1Y